Amdocs Stock Today

DOX Stock  USD 67.26  0.11  0.16%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
Amdocs is trading at 67.26 as of the 25th of February 2026; that is 0.16 percent decrease since the beginning of the trading day. The stock's open price was 67.37. Amdocs has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on December 16, 2025, Representative Gilbert Cisneros of US Congress acquired $15k to $50k worth of Amdocs's common stock.
Business Domain
Software & Services
IPO Date
19th of June 1998
Category
Technology
Classification
Information Technology
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 107.95 M outstanding shares of which 5.36 M shares are currently shorted by investors with about 5.9 days to cover. More on Amdocs

Moving together with Amdocs Stock

  0.9SOP Sopra Steria Group Earnings Call TomorrowPairCorr
  0.8IT GartnerPairCorr
  0.78KD Kyndryl HoldingsPairCorr

Moving against Amdocs Stock

  0.67DM Datametrex AI Earnings Call This WeekPairCorr
  0.61BEO Beonic Earnings Call TomorrowPairCorr
  0.46MI NFT LimitedPairCorr
  0.34FDM FDM Group HoldingsPairCorr
  0.32GNIP GenIP PLCPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Amdocs Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO PresidentJoshua Sheffer
Thematic IdeaIsrael Wall Street (View all Themes)
Old NameDorex Minerals Inc.
Business ConcentrationIT Consulting & Other Services, Software - Infrastructure, Information Technology, Nasdaq Computer, NASDAQ Composite, NASDAQ Composite Total, Israel Wall Street, Information Technology, IT Services, Software—Infrastructure, Technology, Computing (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.06290.0813
Significantly Down
Slightly volatile
Asset Turnover0.840.83
Fairly Up
Pretty Stable
Gross Profit Margin0.410.42
Fairly Down
Pretty Stable
Total Current Liabilities1.1 B1.6 B
Way Down
Slightly volatile
Non Current Liabilities Total1.7 B1.6 B
Sufficiently Up
Slightly volatile
Total Assets4.7 B7.2 B
Way Down
Slightly volatile
Total Current Assets1.9 B1.8 B
Fairly Up
Very volatile
Total Cash From Operating Activities578.1 M861.5 M
Way Down
Slightly volatile
Debt Levels
Amdocs utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Amdocs' leverage profile, showing how much of Amdocs' resources are funded through borrowing.
Liquidity
Amdocs has 826.4 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Amdocs has a current ratio of 1.57, which is typical for the industry and considered as normal. That said, strategic use of leverage may enable Amdocs to fund expansion initiatives and generate superior returns.

Total Cash From Operating Activities

578.09 Million
Amdocs (DOX) is traded on NASDAQ Exchange in USA and employs 26,969 people. Amdocs is listed under IT Consulting & Other Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 7.4 B. Amdocs runs under IT Services sector within Information Technology industry. The entity has 107.95 M outstanding shares of which 5.36 M shares are currently shorted by investors with about 5.9 days to cover. Amdocs has about 817.98 M in cash with 749.1 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.74.
Check Amdocs Probability Of Bankruptcy
Ownership Allocation
The majority of Amdocs outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amdocs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amdocs. Please pay attention to any change in the institutional holdings of Amdocs as this could imply that something significant has changed or is about to change at the company. Please note that on December 16, 2025, Representative Gilbert Cisneros of US Congress acquired $15k to $50k worth of Amdocs's common stock.
Check Amdocs Ownership Details

Amdocs Stock Institutional Holders

InstituionRecorded OnShares
Nordea Investment Mgmt Bank Demark A/s2025-06-30
1.9 M
Geode Capital Management, Llc2025-06-30
1.8 M
Alliancebernstein L.p.2025-06-30
1.8 M
Morgan Stanley - Brokerage Accounts2025-06-30
1.8 M
American Century Companies Inc2025-06-30
1.5 M
State Street Corp2025-06-30
1.5 M
Bank Of America Corp2025-06-30
1.3 M
Alyeska Investment Group, L.p.2025-06-30
1.3 M
Aqr Capital Management Llc2025-06-30
1.1 M
Fmr Inc2025-06-30
16.2 M
Pzena Investment Management, Llc2025-06-30
6.6 M
View Amdocs Diagnostics

Amdocs Historical Income Statement

At this time, Amdocs' Interest Expense is fairly stable compared to the past year. Operating Income is likely to rise to about 994.2 M in 2026, whereas Depreciation And Amortization is likely to drop slightly above 184.2 M in 2026. View More Fundamentals

Amdocs Stock Against Markets

Amdocs Corporate Management

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.